Regenerative therapies company Cytomedix has received clearance from the Therapeutic Goods Administration (TGA) to commercialize its Angel cPRP system in Australia. The approval allows the company to use the system in the clinic or ...
Tags: Cytomedix, TGA, Angel cPRP system
The US Food and Drug Administration (FDA) has granted 510(K) approval to Cytomedix to use its Angel Concentrated Platelet Rich Plasma (cPRP) system to process a small sample of blood or a mixture of blood and bone marrow aspirate. ...